Cancer survival and prevalence in Australia: period estimates from 1982 to 2010

Publication

Release Date: 20 Sep 2012

Author: AIHW

Media release

AIHW

Australian Institute of Health and Welfare 2012. Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Cat. no. CAN 65. Canberra: AIHW.

APA

Australian Institute of Health and Welfare. (2012). Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Canberra: AIHW.

MLA

Australian Institute of Health and Welfare. Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. AIHW, 2012.

Vancouver

Australian Institute of Health and Welfare. Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Canberra: AIHW; 2012.

Harvard

Australian Institute of Health and Welfare 2012, Cancer survival and prevalence in Australia: period estimates from 1982 to 2010, AIHW, Canberra.

Download PDF

PDF | 6.6Mb

Other formats

Enter the email address where you would like the PDF sent. This address will not be used for any other purpose.

This report presents the latest national survival and prevalence statistics for cancers in Australia from 1982 to 2010. Survival from cancer is a key indicator of cancer prognosis, control and treatment. It refers to the probability of being alive for a given amount of time after diagnosis and reflects the severity of a cancer diagnosis.

ISBN: 978-1-74249-338-1
Cat. no: CAN 65
Pages: 198

Findings from this report:

Five-year survival from all cancers combined increased from 47% in the period 1982–1987 to 66% in 2006–2010
Between 1982–1987 and 2006–2010, prostate and kidney cancer, and non-Hodgkin lymphoma had the largest survival gains
In 2006–2010, cancers with the lowest survival were pancreatic cancer and mesothelioma
In 2006–2010, five-year relative survival from all cancers combined was 66%

Preliminary material
- Title and verso pages
- Contents
- Acknowledgments
- Abbreviations
- Summary
- Data at a glance
Body section
- 1 Introduction
  - Purpose and content of this report
  - Scope
- 2 Background
  - Cancer
  - Survival
  - What is prevalence?
  - Data sources
- 3 Survival and prevalence overview
  - All cancers combined (C00-C97, D45-D46, D47.1,D47.3)
  - Differences by cancer type
- 4 Survival and prevalence summaries
  - Acute myeloid leukaemia (C92.0, C92.3-C92.5, C93.0,C94.0, C94.2, C94.4, C94.5)
  - Bladder cancer (C67)
  - Bowel cancer (C18-C20)
  - Brain cancer (C71)
  - Breast cancer in females (C50)
  - Cervical cancer (C53)
  - Chronic lymphocytic leukaemia (C91.1)
  - Cancer of the gallbladder and bile ducts (C23-C24)
  - Hodgkin lymphoma (C81)
  - Kidney cancer (C64)
  - Laryngeal cancer (C32)
  - Lip cancer (C00)
  - Liver cancer (C22)
  - Lung cancer (C33-C34)
  - Melanoma of the skin (C43)
  - Mesothelioma (C45)
  - Myeloma (C90)
  - Non-Hodgkin lymphoma (C82-C85)
  - Oesophageal cancer (C15)
  - Ovarian cancer (C56)
  - Pancreatic cancer (C25)
  - Prostate cancer (C61)
  - Stomach cancer (C16)
  - Testicular cancer (C62)
  - Thyroid cancer (C73)
  - Tongue cancer (C01-C02)
  - Cancer of unknown primary site (C80)
  - Uterine cancer (C54-C55)
End matter
- Appendixes
  - Appendix A: Guide to online supplementary data
  - Appendix B: Survival estimates using the cohort method
  - Appendix C: Data sources
    - Australian Cancer Database
    - National Death Index
    - National Mortality Database
    - Estimated resident populations
  - Appendix D: Classifications of cancers
  - Appendix E: Classifications of population groups
  - Appendix F: Statistical methods and technical notes
    - Data preparation
    - Calculation of relative survival
    - Calculation of age-standardised rates
- Glossary
- References
- List of tables
- List of figures
- Related publications

Find reports & data by topic

Featured

Cancer survival and prevalence in Australia: period estimates from 1982 to 2010

Citation

AIHW

APA

MLA

Vancouver

Harvard

Table of contents

AIHW

Feedback